Skip to main content

Peer Review reports

From: Herceptin® (trastuzumab) in HER2-positive early breast cancer: protocol for a systematic review and cumulative network meta-analysis

Original Submission
5 May 2017 Submitted Original manuscript
23 Jun 2017 Reviewed Reviewer Report - Zahra Madjd
14 Jul 2017 Reviewed Reviewer Report - Xavier Armoiry
14 Aug 2017 Author responded Author comments - Florence Wilson
Resubmission - Version 2
14 Aug 2017 Submitted Manuscript version 2
31 Aug 2017 Reviewed Reviewer Report - Xavier Armoiry
12 Sep 2017 Author responded Author comments - Florence Wilson
Resubmission - Version 3
12 Sep 2017 Submitted Manuscript version 3
22 Sep 2017 Reviewed Reviewer Report - Xavier Armoiry
Resubmission - Version 4
Submitted Manuscript version 4
Publishing
28 Sep 2017 Editorially accepted
10 Oct 2017 Article published 10.1186/s13643-017-0588-2

You can find further information about peer review here.

Back to article page